Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Lizhong Zeng"'
Autor:
Xin Lyu, Lizhong Zeng, Jie Shi, Zongjuan Ming, Wei Li, Boxuan Liu, Yang Chen, Bo Yuan, Ruiying Sun, Jingyan Yuan, Nannan Zhao, Xia Yang, Guoan Chen, Shuanying Yang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-14 (2022)
Abstract Background The contribution of autophagy to cancer therapy resistance remains complex, mainly owing to the discrepancy of autophagy mechanisms in different therapy. However, the potential mechanisms of autophagy-mediated resistance to icotin
Externí odkaz:
https://doaj.org/article/1ebd149d9c5746678e9743ebd921c54a
Publikováno v:
Chinese Journal of Lung Cancer, Vol 25, Iss 4, Pp 226-235 (2022)
Background and objective A lack of effective treatment for lung squamous cell carcinoma (LUSC) makes it an important factor restricting the 5-year survival rate of non-small cell lung cancer (NSCLC). Long non-coding RNA 00668 (LINC00668) was reported
Externí odkaz:
https://doaj.org/article/ed64b8248c4b4fc6b5884cdce8cc5492
Autor:
Juan Ma, Ying Bai, Mei Liu, Tong Jiao, Yang Chen, Bo Yuan, Boxuan Liu, Lizhong Zeng, Zongjuan Ming, Wei Li, Ruiying Sun, Xia Yang, Shuanying Yang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 8, Pp 1126-1135 (2022)
Abstract Background We aimed to explore the correlation between blood lipids (high density lipoprotein cholesterol [HDL‐C] and apolipoprotein A1 [ApoA1]) and epidermal growth factor receptor (EGFR) T790M mutation, as well as its predictive role in
Externí odkaz:
https://doaj.org/article/1bb74746fb444446b023f3aa8fa2fa95
Autor:
Jie Shi, Xin Lv, Wei Li, Zongjuan Ming, Lizhong Zeng, Jingyan Yuan, Yang Chen, Boxuan Liu, Shuanying Yang
Publikováno v:
Thoracic Cancer, Vol 12, Iss 17, Pp 2324-2338 (2021)
Abstract Background Lung cancer accounts for the highest rate of cancer‐related diagnosis and mortality. Lung adenocarcinoma (LUAD) is the most common histopathological type. BCCIP was originally identified as a BRCA2 and CDKN1A interacting protein
Externí odkaz:
https://doaj.org/article/a59b19fd8663452aac43476e7b774bb7
Autor:
Jie Shi, Xin Lv, Lizhong Zeng, Wei Li, Yujie Zhong, Jingyan Yuan, Shanshan Deng, Boxuan Liu, Bo Yuan, Yang Chen, Zongjuan Ming, Xia Yang, Ping Fang, Shuanying Yang, Guoan Chen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-15 (2021)
Abstract Background Circular RNAs (circRNAs) are a new type of extensive non-coding RNAs that regulate the activation and progression of different human diseases, including cancer. However, information on the underlying mechanisms and clinical signif
Externí odkaz:
https://doaj.org/article/4f84252c3ccd496383cf2deb0c119da7
Publikováno v:
Chinese Journal of Lung Cancer, Vol 23, Iss 4, Pp 261-266 (2020)
Since mid-December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outbroken in Wuhan, Hubei Province, China, and spread rapidly to other provinces in China and dozens of countries and regions around the world, becoming the Pub
Externí odkaz:
https://doaj.org/article/60a61e238b894946bb23b1907f64a5fd
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187860 (2017)
Growing evidence indicates that the cross-linked N-telopeptide of type I collagen (NTx) is likely to be involved in the development of bone metastasis among lung cancer patients. We perform a meta-analysis to disclose the correlation between bone met
Externí odkaz:
https://doaj.org/article/4929f40766e146b99ef4cfadb5e50f8c
Autor:
Tianli Shen, Shuanying Yang, Xiaoyan Qu, Zilu Chen, Lizhong Zeng, Xuejun Sun, Yuyao Lin, Meng Luo, Bo Lei, Chenyang Yue, Chunhong Ma, Nan Hu, Wei Wang, Long Zhang
Publikováno v:
Journal of Controlled Release. 358:204-218
Autor:
Lizhong Zeng, Xin Lyu, Jingyan Yuan, Yang Chen, Haimei Wen, Lei Zhang, Jie Shi, Boxuan Liu, Wei Li, Shuanying Yang
Publikováno v:
International Journal of Biological Sciences; 2024, Vol. 20 Issue 4, p1509-1527, 19p
Autor:
Lei Zhang, Xinyue Zhang, Delu Che, Lizhong Zeng, Yu Zhang, Kai Nan, Xinxin Zhang, Hui Zhang, Zengjun Guo
Publikováno v:
Phytotherapy Research. 37:124-139